Atara Biotherapeutics
Market Access/ News/ News/ News/ Oncology
Atara closes on first approval of transplant complication therapy
Phil Taylor
allogeneic, Atara Biotherapeutics, cell therapy, Ebvallo, immuno-oncology, Oncology, Pierre Fabre, tabelecleucel
0 Comment
X
Atara closes on first approval of transplant complication therapy
https://pharmaphorum.com/news/atara-closes-on-first-approval-of-transplant-complication-therapy/
News/ News/ News/ Oncology/ R&D
Bayer bails on $670m CAR-T partnership with Atara
Phil Taylor
Atara Biotherapeutics, Bayer, CAR-T therapies, immuno-oncology, Oncology, partnering
0 Comment
X
Bayer bails on $670m CAR-T partnership with Atara
https://pharmaphorum.com/news/bayer-bails-on-670m-car-t-partnership-with-atara/